Iron homeostasis governs erythroid phenotype in Polycythemia Vera
Blood · 16.03.2023
DOI: 10.1182/blood.2022016779 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood, online erschienen am 16.03.2023. Verfasst von Cavan Bennett und 19 weiteren Autor:innen. Beteiligte Einrichtung: Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. Hauptthemen laut MEDLINE: Polycythemia Vera. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wellcome Trust, Cancer Research UK, Medical Research Council.
Abstract (Originalsprache)
Polycythemia Vera (PV) is a myeloproliferative neoplasm driven by activating mutations in JAK2 that result in unrestrained erythrocyte production, increasing patients' hematocrit and hemoglobin concentration, placing them at risk of life-threatening thrombotic events. Our GWAS of 440 PV cases and 403,351 controls utilizing UK Biobank data found that SNPs in HFE known to cause hemochromatosis are highly associated with PV diagnosis, linking iron regulation to PV. Analysis of the FinnGen dataset independently confirmed over-representation of homozygous HFE variants in PV patients. HFE influences the expression of hepcidin, the master regulator of systemic iron homeostasis. Through genetic dissection of PV mouse models, we show that the PV erythroid phenotype is directly linked to hepcidin expression: endogenous hepcidin upregulation alleviates erythroid disease whereas hepcidin ablation worsens it. Further, we demonstrate that in PV, hepcidin is not regulated by expanded erythropoiesis but is likely governed by inflammatory cytokines signaling via GP130 coupled receptors. These findings have important implications for understanding the pathophysiology of PV and offer new therapeutic strategies for this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
- Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
- Silence Therapeutics GmbH, Berlin, Germany.
- Diagnostic Haematology, The Royal Melbourne Hospital, Parkville, VIC, Australia.
- Department of Infectious Diseases, Peter Doherty Institute, University of Melbourne, Parkville, VIC, Australia.
- Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
ORCID-Profile: Cavan Bennett, Victoria E Jackson, Ute Schaeper, Ricardo Ataide, Andrew Baldi, Alexandra L Garnham, Connie S N Li-Wai-Suen, Stephen J Loughran, E Joanna Baxter, Anthony R Green, Melanie Bahlo, Ashley P Ng, Sant-Rayn Pasricha
Förderung
- Wellcome Trust
- Cancer Research UK
- Medical Research Council
Zitieren
APA
Bennett, C., Jackson, V. E., Pettikiriarachchi, A., Hayman, T., Schaeper, U., Moir-Meyer, G., Fielding, K., Ataide, R., Clucas, D., Baldi, A., Garnham, A. L., Li-Wai-Suen, C. S. N., Loughran, S. J., Baxter, E. J., Green, A. R., Alexander, W. S., Bahlo, M., Burbury, K., Ng, A. P., & Pasricha, S. R. (2023). Iron homeostasis governs erythroid phenotype in Polycythemia Vera. Blood. https://doi.org/10.1182/blood.2022016779
Vancouver
Bennett C, Jackson VE, Pettikiriarachchi A, Hayman T, Schaeper U, Moir-Meyer G, et al. Iron homeostasis governs erythroid phenotype in Polycythemia Vera. Blood. 2023. doi:10.1182/blood.2022016779
BibTeX
@article{Bennett2023,
author = {Bennett, Cavan and Jackson, Victoria E and Pettikiriarachchi, Anne and Hayman, Thomas and Schaeper, Ute and Moir-Meyer, Gemma and Fielding, Katherine and Ataide, Ricardo and Clucas, Danielle and Baldi, Andrew and Garnham, Alexandra L and Li-Wai-Suen, Connie S N and Loughran, Stephen J and Baxter, E Joanna and Green, Anthony R and Alexander, Warren S and Bahlo, Melanie and Burbury, Kate and Ng, Ashley P and Pasricha, Sant-Rayn},
title = {Iron homeostasis governs erythroid phenotype in Polycythemia Vera},
journal = {Blood},
year = {2023},
doi = {10.1182/blood.2022016779}
}
EUVIMED